Reaction profiling of the MAO-B catalyzed oxidative deamination of amines in Alzheimer's disease

Donna M. Gasparro, David R P Almeida, Luca F. Pisterzi, Jason R. Juhasz, B. Viskolcz, B. Penke, I. Csizmadia

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Monoamine oxidase type B (MAO-B) catalyzes the oxidative deamination of various endogenous and exogenous primary, secondary, and tertiary amines. During this reaction, reactive oxygen species (ROS) are produced which contribute to the oxidative stress in a biological system. Further, research has indicated that increased MAO-B levels and increased ROS production may lead to deposition of β-amyloid (Aβ) and act as contributing factors to the pathogenesis of Alzheimer's disease (AD). As such, irreversible MAO-B inhibitors like selegiline, which decrease the rate of MAO-B catalyzed oxidative deamination, and thus the production of ROS, may have therapeutic potential via neuroprotection. In the current study, molecular orbital calculations were performed using the complete basis set 4m (CBS-4m) theoretical framework employed within the GAUSSIAN 98 software to elucidate the full energetic and thermodynamic profile of the MAO-B catalyzed oxidative deamination reaction. Full geometry optimizations were performed on model compounds to reveal the energies (ΔE) and Gibbs Free Energies (ΔG) of the oxidative deamination reaction as a means to clarify the details of this paramount reaction and how it relates to AD and selegiline's therapeutic potential. Results reveal that the oxidative deamination reaction consists of three successive energy-consuming steps for all amines. Trends indicate that for all amines, as amine substitution increases: (1) energetic investments needed for steps 1 and 3 increase, (2) ΔEReaction and ΔGReaction values for the oxidative deamination reaction as a whole increase, (3) differences between ΔGReaction and ΔEReaction values increase, and (4) ΔG and ΔE values for step 2 of the reaction decrease. The second step of the MAO-B catalyzed reaction is the only step, where increased amine substitution correlates with decreased ΔE and ΔG values. Due to the fact that step two possesses the lowest investment of energy for tertiary and secondary amines but the highest investment of energy for primary amines, it can be postulated that MAO-B has preferred secondary and tertiary substrates. The fact that step 2 is the rate-limiting step relates to the notion that it modulates the potential to increase oxidative stress, and thus, must be tightly regulated to maintain oxidant and anti-oxidant homeostasis. Finally, in disease states such as AD, where increased MAO-B levels have been documented, it is possible that MAO-B mediated oxidative stress is a contributing factor to AD. Thus, MAO-B inhibition by drugs like selegiline will provide neuroprotective benefits and help to prevent AD pathogenesis.

Original languageEnglish
Pages (from-to)527-536
Number of pages10
JournalJournal of Molecular Structure: THEOCHEM
Volume666-667
DOIs
Publication statusPublished - Dec 29 2003

Fingerprint

Deamination
oxidase
Monoamine Oxidase
Amines
amines
Alzheimer Disease
Selegiline
Oxidative stress
Reactive Oxygen Species
Oxidative Stress
pathogenesis
Oxidants
Oxygen
oxygen
Substitution reactions
Oxidoreductases
substitutes
Monoamine Oxidase Inhibitors
homeostasis
Orbital calculations

Keywords

  • Alzheimer's disease
  • Complete basis set 4m
  • Monoamine oxidase
  • Monoamine oxidase type B
  • Oxidative deamination
  • Reactive oxygen species

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry
  • Computational Theory and Mathematics
  • Atomic and Molecular Physics, and Optics

Cite this

Reaction profiling of the MAO-B catalyzed oxidative deamination of amines in Alzheimer's disease. / Gasparro, Donna M.; Almeida, David R P; Pisterzi, Luca F.; Juhasz, Jason R.; Viskolcz, B.; Penke, B.; Csizmadia, I.

In: Journal of Molecular Structure: THEOCHEM, Vol. 666-667, 29.12.2003, p. 527-536.

Research output: Contribution to journalArticle

Gasparro, Donna M. ; Almeida, David R P ; Pisterzi, Luca F. ; Juhasz, Jason R. ; Viskolcz, B. ; Penke, B. ; Csizmadia, I. / Reaction profiling of the MAO-B catalyzed oxidative deamination of amines in Alzheimer's disease. In: Journal of Molecular Structure: THEOCHEM. 2003 ; Vol. 666-667. pp. 527-536.
@article{9e70970594304381a080d56a0b9bb863,
title = "Reaction profiling of the MAO-B catalyzed oxidative deamination of amines in Alzheimer's disease",
abstract = "Monoamine oxidase type B (MAO-B) catalyzes the oxidative deamination of various endogenous and exogenous primary, secondary, and tertiary amines. During this reaction, reactive oxygen species (ROS) are produced which contribute to the oxidative stress in a biological system. Further, research has indicated that increased MAO-B levels and increased ROS production may lead to deposition of β-amyloid (Aβ) and act as contributing factors to the pathogenesis of Alzheimer's disease (AD). As such, irreversible MAO-B inhibitors like selegiline, which decrease the rate of MAO-B catalyzed oxidative deamination, and thus the production of ROS, may have therapeutic potential via neuroprotection. In the current study, molecular orbital calculations were performed using the complete basis set 4m (CBS-4m) theoretical framework employed within the GAUSSIAN 98 software to elucidate the full energetic and thermodynamic profile of the MAO-B catalyzed oxidative deamination reaction. Full geometry optimizations were performed on model compounds to reveal the energies (ΔE) and Gibbs Free Energies (ΔG) of the oxidative deamination reaction as a means to clarify the details of this paramount reaction and how it relates to AD and selegiline's therapeutic potential. Results reveal that the oxidative deamination reaction consists of three successive energy-consuming steps for all amines. Trends indicate that for all amines, as amine substitution increases: (1) energetic investments needed for steps 1 and 3 increase, (2) ΔEReaction and ΔGReaction values for the oxidative deamination reaction as a whole increase, (3) differences between ΔGReaction and ΔEReaction values increase, and (4) ΔG and ΔE values for step 2 of the reaction decrease. The second step of the MAO-B catalyzed reaction is the only step, where increased amine substitution correlates with decreased ΔE and ΔG values. Due to the fact that step two possesses the lowest investment of energy for tertiary and secondary amines but the highest investment of energy for primary amines, it can be postulated that MAO-B has preferred secondary and tertiary substrates. The fact that step 2 is the rate-limiting step relates to the notion that it modulates the potential to increase oxidative stress, and thus, must be tightly regulated to maintain oxidant and anti-oxidant homeostasis. Finally, in disease states such as AD, where increased MAO-B levels have been documented, it is possible that MAO-B mediated oxidative stress is a contributing factor to AD. Thus, MAO-B inhibition by drugs like selegiline will provide neuroprotective benefits and help to prevent AD pathogenesis.",
keywords = "Alzheimer's disease, Complete basis set 4m, Monoamine oxidase, Monoamine oxidase type B, Oxidative deamination, Reactive oxygen species",
author = "Gasparro, {Donna M.} and Almeida, {David R P} and Pisterzi, {Luca F.} and Juhasz, {Jason R.} and B. Viskolcz and B. Penke and I. Csizmadia",
year = "2003",
month = "12",
day = "29",
doi = "10.1016/j.theochem.2003.08.077",
language = "English",
volume = "666-667",
pages = "527--536",
journal = "Computational and Theoretical Chemistry",
issn = "2210-271X",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Reaction profiling of the MAO-B catalyzed oxidative deamination of amines in Alzheimer's disease

AU - Gasparro, Donna M.

AU - Almeida, David R P

AU - Pisterzi, Luca F.

AU - Juhasz, Jason R.

AU - Viskolcz, B.

AU - Penke, B.

AU - Csizmadia, I.

PY - 2003/12/29

Y1 - 2003/12/29

N2 - Monoamine oxidase type B (MAO-B) catalyzes the oxidative deamination of various endogenous and exogenous primary, secondary, and tertiary amines. During this reaction, reactive oxygen species (ROS) are produced which contribute to the oxidative stress in a biological system. Further, research has indicated that increased MAO-B levels and increased ROS production may lead to deposition of β-amyloid (Aβ) and act as contributing factors to the pathogenesis of Alzheimer's disease (AD). As such, irreversible MAO-B inhibitors like selegiline, which decrease the rate of MAO-B catalyzed oxidative deamination, and thus the production of ROS, may have therapeutic potential via neuroprotection. In the current study, molecular orbital calculations were performed using the complete basis set 4m (CBS-4m) theoretical framework employed within the GAUSSIAN 98 software to elucidate the full energetic and thermodynamic profile of the MAO-B catalyzed oxidative deamination reaction. Full geometry optimizations were performed on model compounds to reveal the energies (ΔE) and Gibbs Free Energies (ΔG) of the oxidative deamination reaction as a means to clarify the details of this paramount reaction and how it relates to AD and selegiline's therapeutic potential. Results reveal that the oxidative deamination reaction consists of three successive energy-consuming steps for all amines. Trends indicate that for all amines, as amine substitution increases: (1) energetic investments needed for steps 1 and 3 increase, (2) ΔEReaction and ΔGReaction values for the oxidative deamination reaction as a whole increase, (3) differences between ΔGReaction and ΔEReaction values increase, and (4) ΔG and ΔE values for step 2 of the reaction decrease. The second step of the MAO-B catalyzed reaction is the only step, where increased amine substitution correlates with decreased ΔE and ΔG values. Due to the fact that step two possesses the lowest investment of energy for tertiary and secondary amines but the highest investment of energy for primary amines, it can be postulated that MAO-B has preferred secondary and tertiary substrates. The fact that step 2 is the rate-limiting step relates to the notion that it modulates the potential to increase oxidative stress, and thus, must be tightly regulated to maintain oxidant and anti-oxidant homeostasis. Finally, in disease states such as AD, where increased MAO-B levels have been documented, it is possible that MAO-B mediated oxidative stress is a contributing factor to AD. Thus, MAO-B inhibition by drugs like selegiline will provide neuroprotective benefits and help to prevent AD pathogenesis.

AB - Monoamine oxidase type B (MAO-B) catalyzes the oxidative deamination of various endogenous and exogenous primary, secondary, and tertiary amines. During this reaction, reactive oxygen species (ROS) are produced which contribute to the oxidative stress in a biological system. Further, research has indicated that increased MAO-B levels and increased ROS production may lead to deposition of β-amyloid (Aβ) and act as contributing factors to the pathogenesis of Alzheimer's disease (AD). As such, irreversible MAO-B inhibitors like selegiline, which decrease the rate of MAO-B catalyzed oxidative deamination, and thus the production of ROS, may have therapeutic potential via neuroprotection. In the current study, molecular orbital calculations were performed using the complete basis set 4m (CBS-4m) theoretical framework employed within the GAUSSIAN 98 software to elucidate the full energetic and thermodynamic profile of the MAO-B catalyzed oxidative deamination reaction. Full geometry optimizations were performed on model compounds to reveal the energies (ΔE) and Gibbs Free Energies (ΔG) of the oxidative deamination reaction as a means to clarify the details of this paramount reaction and how it relates to AD and selegiline's therapeutic potential. Results reveal that the oxidative deamination reaction consists of three successive energy-consuming steps for all amines. Trends indicate that for all amines, as amine substitution increases: (1) energetic investments needed for steps 1 and 3 increase, (2) ΔEReaction and ΔGReaction values for the oxidative deamination reaction as a whole increase, (3) differences between ΔGReaction and ΔEReaction values increase, and (4) ΔG and ΔE values for step 2 of the reaction decrease. The second step of the MAO-B catalyzed reaction is the only step, where increased amine substitution correlates with decreased ΔE and ΔG values. Due to the fact that step two possesses the lowest investment of energy for tertiary and secondary amines but the highest investment of energy for primary amines, it can be postulated that MAO-B has preferred secondary and tertiary substrates. The fact that step 2 is the rate-limiting step relates to the notion that it modulates the potential to increase oxidative stress, and thus, must be tightly regulated to maintain oxidant and anti-oxidant homeostasis. Finally, in disease states such as AD, where increased MAO-B levels have been documented, it is possible that MAO-B mediated oxidative stress is a contributing factor to AD. Thus, MAO-B inhibition by drugs like selegiline will provide neuroprotective benefits and help to prevent AD pathogenesis.

KW - Alzheimer's disease

KW - Complete basis set 4m

KW - Monoamine oxidase

KW - Monoamine oxidase type B

KW - Oxidative deamination

KW - Reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=1642477641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642477641&partnerID=8YFLogxK

U2 - 10.1016/j.theochem.2003.08.077

DO - 10.1016/j.theochem.2003.08.077

M3 - Article

VL - 666-667

SP - 527

EP - 536

JO - Computational and Theoretical Chemistry

JF - Computational and Theoretical Chemistry

SN - 2210-271X

ER -